StockData
Amgen Inc logo

Amgen Inc

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$465.45−0.56 (-0.12%)

Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%

Amgen Estimated Future Intangible Amortization by Quarter

Estimated Future Intangible Amortization — Year 5 ($M) ($M)

QuarterlyAnnual

Amgen Estimated Future Intangible Amortization: $2,100M in Q2 2026, down 4.5% from a year earlier.

Latest, Q2 2026
2,100
Period ended Jun 30, 2026
Change on a year earlier
-4.5%
2,200 in Q2 2025
History
46 quarters
Since Q1 2015
Sources
40
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-05) ↗

Reported in Form 10-K Goodwill and Other Intangible Assets Note (XBRL).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEstimated Future Intangible Amortization — Year 5 ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20262,100-4.5%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 20262,1000.0%Form 10-Q (filed 2026-05-01) ↗
Q4 2025Dec 31, 20252,2000.0%Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 20252,2000.0%Form 10-Q (filed 2025-11-05) ↗
Q2 2025Jun 30, 20252,2000.0%Form 10-Q (filed 2025-08-06) ↗
Q1 2025Mar 31, 20252,100-4.5%Form 10-Q (filed 2025-05-02) ↗
Q4 2024Dec 31, 20242,200-24.1%Form 10-K (filed 2025-02-14) ↗
Q3 2024Sep 30, 20242,200+100.0%Form 10-Q (filed 2024-10-31) ↗
Q2 2024Jun 30, 20242,200+100.0%Form 10-Q (filed 2024-08-07) ↗
Q1 2024Mar 31, 20242,200+100.0%Form 10-Q (filed 2024-05-03) ↗
Q4 2023Dec 31, 20232,900+38.1%Form 10-K (filed 2024-02-14) ↗
Q3 2023Sep 30, 20231,100-38.9%Form 10-Q (filed 2023-10-31) ↗
Q2 2023Jun 30, 20231,100-38.9%Form 10-Q (filed 2023-08-04) ↗
Q1 2023Mar 31, 20231,100-38.9%Form 10-Q (filed 2023-04-28) ↗
Q4 2022Dec 31, 20222,100+16.7%Form 10-K (filed 2023-02-09) ↗
Q3 2022Sep 30, 20221,8000.0%Form 10-Q (filed 2022-11-04) ↗

Cite this data

StockData. (2026). Amgen Estimated Future Intangible Amortization ($M), quarterly Q1 2015–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/intang-amort-y5

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.